Clinical Trials Logo

Clinical Trial Summary

Tramadol is a centrally acting synthetic analgesic used to treat moderate to moderately severe pain. It has been previously evaluated as a method to reduce pain during labour, but there is always some fear related to its effects (neonatal respiratory depression). The purpose of our study was to evaluate the efficacy of subcutaneous tramadol in regards to pain during labour, duration of labour and neonatal outcomes.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01889979
Study type Interventional
Source Saint Thomas Hospital, Panama
Contact
Status Completed
Phase Phase 3
Start date October 2012
Completion date June 2013

See also
  Status Clinical Trial Phase
Completed NCT00611221 - Massage Therapy Study: Massage Therapy and Labour Outcomes Phase 3